Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
RSNA 2020 is in the books, but that does not mean coverage on Diagnostic Imaging stops. The conference still has a great deal to offer. Later this week, look for the third, and final, installment of videos with David Larson, M.D., professor of radiology at Stanford University, focusing on the ethical questions and challenges surrounding the use of artificial intelligence with patient data and medical imaging.
For the previous two videos with Larson, as well as other RSNA 2020 coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
As the country rounds into the holidays and toward the New Year, cases of COVID-19 are, once again, surging. That makes it all the more critical for providers to be able to identify patients who are infected with the virus and, potentially, learn who will fare better or worse. New research is out this week focusing on this issue – Diagnostic Imaging will report on the role imaging plays later this week.
For additional reporting on the use of imaging to diagnose and assess COVID-19 patients, click here.
Since March, 2020 has been a rough, demanding year, putting radiology in the middle of the worst healthcare crisis seen in a century. But, dealing with the pandemic is not the only health-related event throughout the past 12 months. While radiologists and other healthcare providers were focused on the emergent needs, advancements were still marching on in other areas of medical imaging. This week, Diagnostic Imaging will share some the biggest developments of the year in mammography.
For additional mammography coverage, click here.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.